Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma - where do we stand?

被引：4
|
作者：
Mikolasevic, Ivana [1 ]
Bokun, Tomislav [2 ]
Kanizaj, Tajana Filipec [3 ]
机构：
[1] Univ Rijeka Sch, Univ Hosp Ctr Rijeka, Dept Gastroenterol, Sch Med, Rijeka, Croatia
[2] Univ Zagreb, Univ Hosp Dubrava, Dept Gastroenterol Hepatol & Clin Nutr, Sch Med, Zagreb, Croatia
[3] Univ Zagreb, Univ Hosp Merkur, Dept Gastroenterol, Sch Med, Zagreb, Croatia
来源：
CROATIAN MEDICAL JOURNAL | 2018年 / 59卷 / 03期
关键词：
EPIDEMIOLOGY; METAANALYSIS; ASSOCIATION; SYMPTOMS; OBESITY; CANCER;
D O I：
10.3325/cmj.2018.59.97
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：97 / 99
页数：3
相关论文
共 50 条
  • [31] Helicobacter pylori CagA(-) strains predominate in gastroesophageal reflux disease, Barrett's esophagus, and esophageal dysplasia/adenocarcinoma.
    Schnell, JW
    Vicari, JJ
    PerezPerez, GI
    Falk, GW
    Halter, SA
    Goldblum, JR
    Gangarosa, LM
    Rice, TW
    Richter, JE
    Blaser, MJ
    Peek, RM
    GASTROENTEROLOGY, 1997, 112 (04) : A283 - A283
  • [32] Helicobacter pylori infection does not influence the progression from gastroesophageal reflux disease to Barrett's esophagus to esophageal adenocarcinoma
    Edhi, Ahmed
    Gangwani, Manesh K.
    Aziz, Muhammad
    Jaber, Fouad
    Khan, Zubair
    Inamdar, Sumant
    Thrift, Aaron P.
    Desai, Tusar K.
    MINERVA GASTROENTEROLOGY, 2024, 70 (04): : 454 - 462
  • [33] Helicobacter pylori Infection Might Contribute to Esophageal Adenocarcinoma Progress in Subpopulations With Gastroesophageal Reflux Disease and Barrett's Esophagus
    Kountouras, Jannis
    Chatzopoulos, Dimitrios
    Zavos, Christos
    Polyzos, Stergios A.
    Giartza-Taxidou, Evaggelia
    Vardaka, Elizabeth
    Molyvas, Epaminondas
    Kouklakis, George
    Tsiaousi, Elena
    Klonizakis, Philippos
    HELICOBACTER, 2012, 17 (05) : 404 - 405
  • [34] Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited
    Lada, Michal J.
    Nieman, Dylan R.
    Han, Michelle
    Timratana, Poochong
    Alsalahi, Omran
    Peyre, Christian G.
    Jones, Carolyn E.
    Watson, Thomas J.
    Peters, Jeffrey H.
    SURGERY, 2013, 154 (04) : 856 - 864
  • [35] Helicobacter pylori infection does not influence the progression from gastroesophageal reflux disease to Barrett's esophagus to esophageal adenocarcinoma
    Edhi, Ahmed
    Gangwani, Manesh K.
    Aziz, Muhammad
    Jaber, Fouad
    Khan, Zubair
    Inamdar, Sumant
    Thrift, Aaron P.
    Desai, Tusar K.
    MINERVA GASTROENTEROLOGY, 2024,
  • [36] Adherence to quality indicators of Barrett's esophagus surveillance: where do we stand?
    Westerveld, Donevan
    Yang, Dennis
    ENDOSCOPY, 2017, 49 (11) : 1113 - 1113
  • [37] From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma
    Rui-Hua Wang
    World Journal of Gastroenterology, 2015, 21 (17) : 5210 - 5219
  • [38] Familial gastroesophageal reflux: Association with Barrett's esophagus and adenocarcinoma.
    Romero, Y
    Cameron, AJ
    Locke, GR
    Schaid, DJ
    Melton, LJ
    Slezak, J
    GASTROENTEROLOGY, 1997, 112 (04) : A272 - A272
  • [39] From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma
    Wang, Rui-Hua
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (17) : 5210 - 5219
  • [40] Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited DISCUSSION
    Melvin, W. Scott
    Lada, Michal
    Ferri, Lorenzo
    Brunt, L. Michael
    SURGERY, 2013, 154 (04) : 864 - 866
12345